TFSA Investors: 2 Growth Stocks That Can Turn $6,000 Into $15,000 by 2025

Beaten-down growth stocks such as WELL Health and Teladoc Health should be part of your TFSA portfolio watchlist at current prices.

| More on:
healthcare pharma

Image source: Getty Images

Growth stocks have experienced a massive decline in the last three months due to a variety of reasons that include the possibility of multiple interest rate hikes and steep valuations. But if you look at historical trends, every market crash offers investors an opportunity to buy quality businesses at a cheaper valuation.

Here, we look at two growth stocks in WELL Health (TSX:WELL) and Teladoc Health (NYSE:TDOC) that should be up for consideration as part of your TFSA portfolio right now. The contribution room for your TFSA stands at $6,000 for 2022. The registered account is ideal to hold growth stocks over the long term as any withdrawals from the TFSA are exempt from Canada Revenue Agency taxes.

WELL Health Technologies

Valued at a market cap of $857 million, WELL Health stock is down 57% from all-time highs. Despite the pullback, the stock has returned over 4,000% to investors since its IPO in 2016. The health-tech company has increased sales from $5.89 million in 2018 to $50.24 million in 2020.

Now, WELL Health stated it expects to announce record financial performance in Q4 of 2021 with an annualized revenue run-rate of more than $450 million and an annualized operating adjusted EBITDA run-rate of almost $100 million. Additionally, its total number of omni-channel patient visits in Q4 more than doubled year over year to 692,913.

A key reason for the company’s stellar top-line growth is its focus on accretive acquisitions. It acquired entities such as Circle Medical and Wisp in 2021 that will drive revenue higher in the upcoming quarters. Further, WELL is also on track to deliver US$43 million in free cash flow in 2021.

Analysts tracking WELL Health expect sales to touch $298 million in 2021 and rise by 63.4% to $488 million in 2022. So, WELL stock is trading at a forward price to sales multiple of less than two times which is really cheap.

Bay Street has a 12-month average price target of $11.2 for WELL stock, which is 170% above its current trading price.

Teladoc Health

Shares of Teladoc Health have declined by 77% from all-time highs, valuing the company at a market cap of US$10.8 billion. The COVID-19 pandemic increased demand for Teladoc’s suite of services at an accelerated pace, allowing it to almost double its sales. However, investors must also note that Teladoc increased sales at an annual rate of 74% in seven years prior to the pandemic.

There are some concerns over Teladoc’s ability to grow revenue in a post-pandemic world. But, in Q3 of 2021, online visits on the Teladoc platform rose by 37% year over year. Further, a report from Allied Market Research has estimated the global telehealth industry to touch US$430 billion by 2030, indicating annual growth rates of 25%.

Teladoc aims to grow sales at an annual rate of between 25% and 30% through 2024, allowing it to touch US$4 billion in sales by end of the forecast period.

At the current price, TDOC stock is valued at a forward price to sales multiple of four, which is quite reasonable. Wall Street expects TDOC stock to gain over 100% in the next 12-months to trade around US$141 per share.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Teladoc Health.

More on Tech Stocks

Lady holding mobile phone and shopping bags
Tech Stocks

The Ultimate Growth Stock to Buy With $1,000 Right Now 

Here's why Shopify (TSX:SHOP) could be the ultimate growth stock long-term investors want to consider at this current point in…

Read more »

Hands shaking over a business deal
Tech Stocks

Meet the Growth Stock I Can’t Stop Buying This Year

Topicus stock (TSXV:TOI) has been a top growth stock this year, with strong finances, a stable acquisition strategy, and more…

Read more »

grow dividends
Tech Stocks

Celestica Stock Is up 44% Since Earnings: What Investors Need to Know

Celestica continues to benefit from strong demand and production efficiencies, yet the stock remains undervalued.

Read more »

healthcare pharma
Tech Stocks

What’s Going on With WELL Health Stock?

WELL stock (TSX:WELL) made strong moves once again, with record earnings and even higher guidance for 2024.

Read more »

A shopper makes purchases from an online store.
Tech Stocks

3 Reasons to Buy Shopify Stock Right Now

Based on these three top reasons, Shopify (TSX:SHOP) stock appears undervalued to buy right now.

Read more »

stock research, analyze data
Tech Stocks

What’s Going on With Lightspeed Stock?

Lightspeed (TSX:LSPD) stock has been climbing once more but is still far from its three-digit share price. So, is it…

Read more »

Target. Stand out from the crowd
Tech Stocks

Missed Out on Nvidia Stock (Again)? Buy Descartes Instead

Nvidia (NASDAQ:NVDA) stock soared yet again after earnings, passing the four-digit mark. But with shares so high, maybe this option…

Read more »

Group of people network together with connected devices
Tech Stocks

This Is the Best Overlooked AI Stock on the TSX Today

This AI stock has been a top growing in the last while, but remains overlooked despite its strong portfolio and…

Read more »